Frontlight ResearchEarly access
WithdrawnNo phase
Effect of Obstructive Sleep Apnea on Glucose Control and Cognitive Function
Key facts
- Who runs it
- Chinese University of Hong Kong
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Withdrawn
- Started
- 1 Nov 2021
- Ended
- 30 Nov 2023
- Type of study
- Interventional
- Treatments tested
- Lifestyle modification program
- Record updated
- 20 February 2024
- Why it stopped
- no funding
Who can take part
- Age
- 40 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- BMI ≥ 25kg/m2
- impaired glucose tolerance which defined as plasma glucose at the range of 7.8 and 11 mmol/l 2 hours after 75g oral glucose solution intake,
- willing to participate in lifestyle modification program
- and capable of using continuous glucose monitoring (CGM) as judged by investigator
Who cannot take part
- current participation in other weight loss or lifestyle interventions, or use of weight loss drugs,
- current use of steroids
- known obstructive sleep apnea on continuous positive airway pressure therapy
- unstable cardiovascular disease (e.g. recent unstable angina or myocardial infarction within the previous 6 months or severe left ventricular failure; neuromuscular disease affecting or potentially affecting respiratory muscles; moderate to severe respiratory disease (i.e. breathlessness affecting activities of daily living) or documented hypoxemia or awake SaO2 <92%)
- Use of psychoactive medication
- allergy to medical grade adhesives
- uncontrolled hypertension (blood pressure >140/90mmHg) or requiring more than two anti-hypertensive medication
- history of stroke or brain injury,
- psychiatric disease that limits the ability to give informed consent or complete the study
- known diabetes, current or previous use of glucose lowering drug
- Lactating or pregnant,
- uncontrolled thyrotoxicosis
- symptoms of cognitive deterioration (according to the Hong Kong Montreal Cognitive Assessment (HK-MoCA) at the score of <21)
- predominant central sleep apnea
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Obstructive sleep apnea (OSA) may contribute to altered cognitive function in patients suffering from severe OSA. And lifestyle modification program may improve the cognitive function after 6 months of therapy.
The group in the trial
- Lifestyle modification programOther group
Patients with obstructive sleep apnea and prediabetes will have lifestyle modification program for 12 months
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of Obstructive Sleep Apnea on Glucose Control and Cognitive Function - a Substudy of 'Continuous Glucose Monitoring as an Adjunct to Lifestyle Modification in Individuals With Impaired Glucose Tolerance: a Randomised Controlled Trial'
- Record updated
- 20 February 2024